Pharvaris (PHVS) Operating Leases (2021 - 2026)
Pharvaris' (PHVS) quarterly Operating Leases came in at $623515.7 in Q1 2026, up 8.49% YoY from $574727.6 in Q1 2025, and down 7.1% on a QoQ basis from $671170.0 in Q4 2025.
Analysis
Pharvaris (PHVS) Operating Leases (2021 - 2026) Analysis & Trends
Pharvaris (PHVS) has 6 years of Operating Leases data on file, last reported at $623515.7 in Q1 2026.
- Quarterly Operating Leases rose 8.49% year-over-year to $623515.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $623515.7 (up 8.49% YoY) and the FY2025 annual result came in at $651432.2, down 5.82% from the prior year.
- Operating Leases fell to $623515.7 in Q1 2026, from $671170.0 in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $682878.4 in Q4 2024 to a low of $19218.8 in Q3 2024.
- A 5-year average of $280877.0 and a median of $137494.2 in 2022 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2024 — Operating Leases slumped 81.61% — and 2025, when it jumped 2582.78%.
- Tracing PHVS's Operating Leases over 5 years: stood at $254468.1 in 2022, then tumbled by 81.58% to $46872.2 in 2023, then soared by 1356.89% to $682878.4 in 2024, then retreated by 1.71% to $671170.0 in 2025, then declined by 7.1% to $623515.7 in 2026.
- The last three Operating Leases figures came in at $623515.7 (Q1 2026), $671170.0 (Q4 2025), and $515600.1 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Pharvaris | 2.10 Bn | 1.73 Bn | 85,072.10 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 559.48 Bn |
| Mar 31, 2026 | 623.52 Bn |
| Dec 31, 2025 | 671.17 Bn |
| Sep 30, 2025 | 515,600.06 |
| Jun 30, 2025 | 534,970.94 |
| Mar 31, 2025 | 574,727.57 |
| Dec 31, 2024 | 682.88 Bn |
| Sep 30, 2024 | 19,218.84 |
| Jun 30, 2024 | 47,113.83 |
| Mar 31, 2024 | 76,045.32 |
| Dec 31, 2023 | 46.87 Bn |
| Sep 30, 2023 | -317,158.66 |
| Jun 30, 2023 | 120.12 Bn |
| Mar 31, 2023 | -414,865.93 |
| Dec 31, 2022 | 254.47 Bn |
| Sep 30, 2022 | 87,250.01 |
| Jun 30, 2022 | 108,939.02 |
| Mar 31, 2022 | 137,494.23 |
| Dec 31, 2021 | 172.46 Bn |
| Sep 30, 2021 | 202,207.68 |